Innovative Drugs At Center Of China’s 2024 Regulatory Efforts
Review Process, Pricing And Insurance On Agenda
China's regulations for the biopharma industry centered around innovative drugs in 2024; in 2025, it may be a continuation of that. (Shutterstock) 
